State News

Displaying results 1-10 (of 75)
 |<  < 1 2 3 4 5 6 7 8  >  >| 

CSRO Delivers Testimony on Utah Step Therapy

On September 20, 2017, Dr. Joshua Stolow traveled to Utah to testify on the necessity of patient protection legislation addressing step therapy protocols.

READ MORE

Legal Challenges to Nevada Drug Transparency Law Forecast Future Hurdles for Lawmakers

Nevada Governor Brian Sandoval signed a landmark drug transparency law in June that focuses on diabetes drug manufacturers and their intermediaries more broadly.

READ MORE

Step-Therapy Legislation Nears Effective Enrollment Date in Texas

Patients and physicians in Texas won a major victory against the step-therapy protocols instituted by insurance companies this spring with the passage of Senate Bill 680.

READ MORE

FDA Creates Pathway for Interchangeable Biologics

The FDA has released its highly anticipated but long delayed interchangeability guidelines, and the market seems primed for new developments.

READ MORE

States move to enforce FDA’s Biosimilar Interchangeability Guidelines from the Ground Up

The Food and Drug Administration’s guidelines for biosimilar interchangeability, released in January 2017, have come under renewed focus with concerns about patients being switched onto biosimilars by insurers without consultation with their physicians.

READ MORE

California Takes Aim at Pharmacy Benefit Managers With Assembly Bill 315

California’s Assembly Bill 315, which takes aim at Pharmacy Benefit Managers (PBMs), recently cleared the Assembly floor, and is now headed to the Senate for consideration.

READ MORE

State Rheumatology Organizations Join Alliance for Transparent & Affordable Prescriptions

The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.

READ MORE

The Atlantic Hosts Biosimilars Policy Roundtable.

The Atlantic recently concluded its policy roundtable on biosimilars June 7th, with the third and final installment titled: “The Next Drugs: An Atlantic Policy Update on Biosimilars.”

READ MORE

Maryland Enacts Biosimilars Bill

Maryland became the 35th state to approve of regulations and access for biosimilar medicines.

READ MORE

Minnesota Enacts HF712

Minnesota's Governor signed HF712 into law, a bill for biosimilars.

READ MORE

Displaying results 1-10 (of 75)
 |<  < 1 2 3 4 5 6 7 8  >  >|